Detection and consequences of recombinant protein isoforms: implications for biological potency
Related Experiment Video
Updated: Jul 24, 2026

High-throughput Purification of Affinity-tagged Recombinant Proteins
Published on: August 26, 2012
M M Federici Jamrogowicz1, K Venkat, N Bam
1Biopharmaceutical Development, GlaxoSmithKline, King of Prussia, PA 19406, USA.
Abstract:
Protein isoforms commonly occur in nature and in products produced by recombinant DNA technologies. Some isoforms may be generated as a consequence of the manufacturing process. Bioassay methods may not be sufficiently sensitive enough or specific enough to determine the biological effect of having a new or increased level of a particular isoform. Sophisticated analytical techniques exist for the structural characterization of protein isoforms. The biological implications of these isoforms are not easy to determine. Additional "Biological Characterization" work may need to be done to evaluate the biological consequences of isoforms. An understanding of the product's mechanism of action and the disease mechanism of action is essential for a thorough evaluation.
Related Concept Videos
Recombinant DNA
Tagging and Fusion Proteins
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Drug Products: Biologics, Biosimilars and Interchangeables

